Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

6550--Intent to Sole Source: GEM-X EPI Multiome Reagents, 10x Genomics, Inc.

Active
36C24226Q0740Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Veterans Affairs intends to award a sole source, firm fixed-price contract to 10x Genomics, Inc. for the purchase of GEM-X Epi Multiome Reagents and associated chip kits under Federal Acquisition Regulation 13.106-1(b)(1)(ii), which permits non-competitive procurement from a single source when only one responsible supplier exists. The contract, identified by solicitation number 36C24226Q0740, is for one unit each of the 16-sample and 4-sample GEM-X Epi Multiome reagent kits and one unit of the 4-chip kit, totaling four items, with a performance period ending on July 2, 2026. The NAICS code 325413 applies, classifying the procurement under In-Vitro Diagnostic Substance Manufacturing, with a size standard of 1,250 employees, and no set-aside is designated. The contract will be performed at the VA Healthcare System facility in Bronx, New York, and all delivered goods are intended for use within the VA healthcare network. This notice serves solely as an announcement of intent and is not a solicitation; no proposals or quotations are being requested at this time. Interested parties may submit expressions of interest, including technical and pricing information, to demonstrate their ability to provide comparable products, but such submissions will only be considered to determine whether competitive procurement is feasible. All submissions must be emailed to jonatan.rondon@va.gov by 4:00 p.m. EST on July 2, 2026, and are the responsibility of the submitter to ensure timely receipt. The government retains full discretion in deciding whether to proceed with sole source award or open the requirement to competition based on responses received. No inquiries via phone or email regarding the notice will be addressed, and no contract will be awarded based on responses to this notice unless further action is taken by the agency.

General Info

VA plans sole-source award to 10x Genomics for Epi Multiome reagents and chips, ending July 2, 2026, for Bronx facility use.

Agency

Department Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)View Agency

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

NY

Set-Aside

NONE

Documents

(1)

Intent to Sole Source: GEM-X EPI Multiome Reagents, 10x Genomics, Inc. - Solicitation 36C24226Q0740

DOCXpresolicitation

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)
Contacts1 person available
OfficeALBANY, NY, 12208, USA
Organization / Agency
Department Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)
View Agency Profile
Office AddressALBANY, NY, 12208, USA
Contacts
Jonatan RondonContracting Officer

Full Description

Show more
Notice of intent to award a sole source, open market contract to 10x Genomics, Inc.
SOL: 36C24226Q0740 DUE: 07/02/2026 SET ASIDE: N/A NAICS: 325413 POP STATE: 30 Days ARO AGENCY: Department of Veterans Affairs; VA Healthcare System, 130 West Kingsbridge Road, Bronx, NY 10468. Email: Jonatan.rondon@va.gov The Department of Veterans Affairs, Margaret Cochran Corbin VA Campus, intends to award an open market, one time firm fixed-price, sole source contract to 10x Genomics, Inc. the authority of Federal Acquisition Regulation (FAR) 13.106-1(b) (1)(ii) to 10x Genomics, Inc. located at 6230 Stoneridge Mall Road, Pleasanton, CA 94588 for their GEM-X Epi Multiome Reagents.
Product Code Product Unit Quantity 1000979 GEM-X Epi Multiome, 16 Samples EA 1 1000980 GEM-X Epi Multiome, 4 samples EA 1 1000980 GEM-X Epi Multiome, 4 samples EA 1 1000951 GEM-X Epi Multiome Chip Kit, 4 chips EA 1
10x Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton, California, 94588-3260 United States
This procurement is being conducted in accordance with FAR 13.106-1(b) (1)(ii), Soliciting from a Single Source. The NAICS code utilized for this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing with a Size Standard of 1,250 employees.
This Notice of Intent is not a request for Proposals or Quotations. No solicitation document exists, and no telephone or email inquiries will be accepted. No contract award will be made on the basis of proposals, or quotations received in response to this notice. Interested persons may identify their interest and capability to respond to the requirement and should furnish detailed data concerning their capabilities to provide services sought including pricing data and technical data sufficient enough to determine that a comparable source to the government is available. The government may consider all Expressions of Interest received prior to July 2nd, 2026. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Responses to this notice must be emailed to jonatan.rondon@va.gov and received by 16:00 hours EST on July 2nd, 2026. Submitters are responsible for ensuring their EOI reaches the designated contracting officer on-time.

Similar Contracts

NAICS: 325413
New
Federal
Vela Diagnostics Sequencing System for HIV-1 Genotype TestingThe Walter Reed Army Institute of Research, through the Defense Health Agency Contracting Activity, is seeking information from industry regarding the availability of a Vela Diagnostics sequencing system for HIV-1 genotype testing, including all required sub-systems, maintenance, repair, and consumables. This Request for Information and Sources Sought Notice, identified as HT9426-26-RFI-5892, is strictly for market research and planning and does not constitute a solicitation, request for proposal, or any obligation by the government to award a contract. Responses are not offers and will not be accepted to form a binding agreement. All submissions must be received by 11:00 a.m. EST on July 9, 2026, and are to be submitted electronically to the designated points of contact. Responders must be registered in SAM.gov under NAICS code 325413 and must address their ability to meet the specified Minimum Essential Characteristics, including the requirement that only the Vela Sentosa brand system be considered due to its FDA approval and use in a CAP-accredited laboratory environment. Responsible parties must submit a concise capabilities statement not exceeding three pages in Microsoft Word or Adobe PDF format, including a cover page with organizational details, technical and administrative points of contact, registered UEI, and listing of any applicable government contracting vehicles. Responses must clearly demonstrate the capability to supply the exact brand system and associated consumables, and confirm whether similar products are available commercially to the public. No reimbursement will be provided for response-related expenses, and all submitted information will be treated as confidential if properly marked proprietary. No evaluations will be issued, and no follow-up questions regarding future solicitations will be addressed. The system is critical for monitoring drug-resistant HIV-1 mutations in military personnel and beneficiaries, and the requirement is focused exclusively on maintaining continuity of testing capability using the existing FDA-approved Vela platform.
Army Medical Resources Acq Activity

POSTED

2 days ago

DEADLINE

in 12 days
View Details